Today, in Atlanta, on July 8, 2026, UCB, a leading biopharmaceutical firm, unveiled the winners of its yearly UCB Myasthenia Gravis Scholarship. A total of 15 scholarships have been granted to recipients in the United States who are either personally affected by myasthenia gravis (MG) or are caregivers to those with the condition.